Shreyas Kalantri/X
Aug 4, 2025, 14:54
Shreyas Kalantri: Engaging Insights on VTE Management
Shreyas Kalantri, Hematology and Oncology Chief Fellow at UofL Brown Cancer Center, shares an insight on VTE management on X:
”VTE management doesn’t stop at anticoagulation. Here are pearls to sharpen your heme boards prep and clinical instincts.
1. Thrombus extension after starting anticoagulation ≠ treatment failure.
Asymptomatic progression can happen in the first 1–2 weeks. No need to escalate therapy unless clinically indicated.”
Dr. Shreyas Kalantri offers engaging and thought‑provoking insights to help you refine and master your clinical reasoning—well worth following.
Stay tuned with Hemostasis Today.
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks